Jack D. Chan
Parkville, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors.
Journal: Nature communications
Published: March 04, 2024
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity.
Journal: Cell reports
Published: February 07, 2024
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy.
Journal: Nature
Published: February 13, 2023
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity.
Journal: Cell reports
Published: August 12, 2022
A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 27, 2021
Cellular networks controlling T cell persistence in adoptive cell therapy.
Journal: Nature reviews. Immunology
Published: March 11, 2021
Chimeric antigen receptor T cell therapies for thoracic cancers-challenges and opportunities.
Journal: Journal of thoracic disease
Published: September 18, 2020
MAIT cells regulate NK cell-mediated tumor immunity.
Journal: Nature communications
Published: July 28, 2020
p38 Kinase: A Key Target for Driving Potent T Cells for Adoptive Immunotherapy.
Journal: Cancer cell
Published: June 10, 2020
Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cells.
Journal: Clinical & translational immunology
Published: April 04, 2020
Enterotoxins can support CAR T cells against solid tumors.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 27, 2019
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity.
Journal: Nature immunology
Published: October 15, 2019
Last Updated: 09/26/2026